Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:awarded |
Prix Galien Award
|
| gptkbp:CEO |
gptkb:Maurice_R._Ferré
|
| gptkbp:focusesOn |
treatment of essential tremor
treatment of Parkinson's disease oncology applications |
| gptkbp:foundedYear |
1999
|
| gptkbp:headquartersLocation |
gptkb:Haifa,_Israel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Insightec
|
| gptkbp:industry |
medical device
|
| gptkbp:investor |
gptkb:Koch_Disruptive_Technologies
gptkb:York_Capital_Management Elbit Imaging |
| gptkbp:notableFor |
MR-guided focused ultrasound
non-invasive treatments for neurological disorders |
| gptkbp:numberOfEmployees |
over 300
|
| gptkbp:operatesIn |
global
|
| gptkbp:product |
Exablate Neuro
Exablate Prostate |
| gptkbp:receivedFDAApproval |
2016
|
| gptkbp:specializesIn |
focused ultrasound technology
|
| gptkbp:subsidiary |
Elbit Medical Technologies
|
| gptkbp:website |
https://www.insightec.com/
|
| gptkbp:bfsParent |
gptkb:Koch_Disruptive_Technologies
|
| gptkbp:bfsLayer |
6
|